Table 3 Baseline clinical characteristics of the enrolled patients
From: Bone marrow-derived stem cells ameliorate hepatic fibrosis by down-regulating interleukin-17
Characteristics | Patients (n=42) |
|---|---|
Sex(m:f) | 30:12 |
Age(year) | 45.8±8.9 |
Albumin(37-55 g/L) | 29.25±3.80 |
Total bilirubin(3.4-20.5 umol/L) | 33.8±18.25 |
prothrombin time(11.0-15.0s) | 19.13±2.98 |
ALT(0-40 IU/L) | 50.83±27.12 |
CTP score | 9.05±1.94 |
MELD score | 14.04±4.89 |